Citius Oncology
CTOR
23 hedge funds and large institutions have $62.6M invested in Citius Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more capital invested
Capital invested by funds: $56.8M → $62.6M (+$5.82M)
5% more funds holding
Funds holding: 22 → 23 (+1)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$2.85M |
| 2 |
KC
Kepos Capital
New York
|
+$2.4M |
| 3 |
MSU
Mizuho Securities USA
New York
|
+$550K |
| 4 |
CAC
Cowen and Company
New York
|
+$302K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$81.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$774K |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$455K |
| 3 |
VF
Virtu Financial
New York
|
-$323K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$119K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$21.4K |
CTOR Hedge Fund Activity: Q3 2023 in Review
23 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Citius Oncology (CTOR) for Q3 2023, worth a combined $62.6M — up 10% from $56.8M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CTOR positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $2.85M. The largest seller was Bank of Montreal, exiting entirely with an estimated $774K sold.
- 23 institutional investors held Citius Oncology (CTOR) as of Q3 2023, up from 22 in Q2 2023.
- Funds reported $62.6M of Citius Oncology stock for Q3 2023, up 10% quarter-over-quarter.
- 3 funds opened new Citius Oncology positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest Citius Oncology buyer in Q3 2023 was Shaolin Capital Management, an estimated $2.85M added.
- The largest Citius Oncology seller in Q3 2023 was Bank of Montreal, an estimated $774K sold.
Based on aggregated 13F filings for Q3 2023.